Labcorp announces 2024 second quarter results

Updates full-year guidance results from continuing operations for second quarter 2024 versus last year: revenue: $3.22 billion versus $3.03 billion diluted eps: $2.43 versus $1.74 adjusted eps: $3.94 versus $3.42 free cash flow: $432.9 million versus $58.2 million updated full-year 2024 guidance: revenue range of 6.4% to 7.5%, includes invitae impact of ~1.0% adjusted eps range of $14.30 to $14.90, includes invitae dilution of ~$0.40 free cash flow of $0.85 billion to $1.00 billion, includes invitae cash usage of ~$150 million share repurchase authorization increased by $1.0 billion to $1.4 billion launched important new tests in specialty testing areas introduced labcorp global trial connect, a suite of central laboratory solutions aimed to accelerate clinical trials burlington, n.c. , aug. 1, 2024 /prnewswire/ -- labcorp (nyse: lh), a global leader of innovative and comprehensive laboratory services, today announced results for the second quarter ended june 30, 2024 and updated full-year guidance.
LH Ratings Summary
LH Quant Ranking